| Name | (1R,4S) Sertraline Hydrochloride |
|---|---|
| Synonyms |
trans-(1R)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Hydrochloride
Trans-(1S)(1R)-N-methyl-4-(3,4-diclorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Hydrochloride trans-(1R,4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride (1R,4S)-sertraline hydrochloride (1R-trans)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1--naphthalenamine Hydrochloride (1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-Methyl-1-naphthalenaMine (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine hydrochloride |
| Boiling Point | 443.8ºC at 760 mmHg |
|---|---|
| Melting Point | 260-262ºC |
| Molecular Formula | C17H18Cl3N |
| Molecular Weight | 342.69100 |
| Flash Point | 222.2ºC |
| Exact Mass | 341.05000 |
| PSA | 12.03000 |
| LogP | 6.37250 |
|
~%
79896-32-5 |
| Literature: Pfizer Inc. Patent: US4556676 A1, 1985 ; US 4556676 A |
| Precursor 1 | |
|---|---|
| DownStream 0 | |